Clinical Trial Update: Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Denosumab (Prolia®) in Routine Clinical Practice

View source ↗

Summary

Prospective observational study describing how denosumab (Prolia) is used in routine clinical practice for osteoporosis, including postmenopausal patients, with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Denosumab (denosumab)
• Prolia (denosumab)

Snippet

Sponsor: Amgen | Conditions: Osteoporosis, Postmenopausal | Status: COMPLETED | Results posted: 2016-05-26